Home > Cashflow Statement > BIOCON

BIOCON
Cash Flow from Financing Activities

    Back to Cashflow Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-2,333 Cr₹13,049 Cr₹242 Cr₹2,564 Cr₹388 Cr

What is the latest Cash Flow from Financing Activities ratio of BIOCON ?

The latest Cash Flow from Financing Activities ratio of BIOCON is ₹-2,333 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-2,333 Cr
Mar2023₹13,049 Cr
Mar2022₹242 Cr
Mar2021₹2,564 Cr
Mar2020₹388 Cr

How is Cash Flow from Financing Activities of BIOCON Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-2,333 Cr
Negative
Mar2023 ₹13,049 Cr
5,289.80
Mar2022 ₹242 Cr
-90.56
Mar2021 ₹2,564 Cr
561.51
Mar2020 ₹388 Cr -

Compare Cash Flow from Financing Activities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹36,642.3 Cr -11.7% -8.5% 19.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,394.0 Cr -6.7% 2.6% 5% Stock Analytics
DIVIS LABORATORIES ₹142,920.0 Cr -6.6% -3.7% 43.8% Stock Analytics
CIPLA ₹114,383.0 Cr -5.3% -2.9% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,817.0 Cr -3.8% 1.8% 25.8% Stock Analytics
DR REDDYS LABORATORIES ₹91,385.4 Cr -4.9% -3.3% -10.2% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-11.7%

-8.5%

19.1%

SENSEX

-3.6%

-0.7%

-0.5%


You may also like the below Video Courses